Literature DB >> 7372711

Role of serum components in density-dependent inhibition of growth of cells in culture. Platelet-derived growth factor is the major serum determinant of saturation density.

A Vogel, R Ross, E Raines.   

Abstract

The effects of platelet-derived growth factor and plasma components on saturation density in cultures of 3T3 cells were investigated. Both of these components of whole blood serum affect saturation density; however, when 3T3 cells become quiescent at high density in medium containing whole blood serum, only platelet-derived growth factor and fresh whole blood serum are capable of stimulating proliferation. Addition of fresh plasma- derived serum has little effect on cell growth. These results suggest that the platelet factor is the major determinant of saturation density in cultures of 3T3 cells maintained in medium supplemented with whole blood serum. Experiments were performed to investigate the mechanism by which platelet-derived growth factor regulates saturation density. We investigated the possibilities of inactivation of growth factors by proliferating cells, and the effects of cell density on the response of 3T3 cells to platelet-derived growth factor. The amount of platelet- derived growth factor required to initiated DNA synthesis increases with increasing cell density. Some inactivation of growth factors by growing cells was detected, but this depletion was only evident at high cell density. We propose that density-dependent inhibition in cultured 3T3 cells is the result both of an increased requirement for the platelet- derived growth factor as the cultures become more crowded and of inactivation of growth factor activity by growing cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7372711      PMCID: PMC2110621          DOI: 10.1083/jcb.85.2.377

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  30 in total

1.  Conditions limiting multiplication of fibroblastic and epithelial cells in dense cultures.

Authors:  R Dulbecco; J Elkington
Journal:  Nature       Date:  1973-11-23       Impact factor: 49.962

2.  Role of diffusion boundary layer in contact inhibition of growth.

Authors:  M G Stoker
Journal:  Nature       Date:  1973-11-23       Impact factor: 49.962

3.  Isolation and characterization of revertant cell lines. II. Growth control of a polyploid revertant line derived from SV40-transformed 3T3 mouse cells.

Authors:  R Pollack; A Vogel
Journal:  J Cell Physiol       Date:  1973-08       Impact factor: 6.384

4.  Topoinhibition and serum requirement of transformed and untransformed cells.

Authors:  R Dulbecco
Journal:  Nature       Date:  1970-08-22       Impact factor: 49.962

5.  Stimulation of cell growth in vitro by serum with and without growth factor. Relation to contact inhibition and viral transformation.

Authors:  J L Jainchill; G J Todaro
Journal:  Exp Cell Res       Date:  1970-01       Impact factor: 3.905

6.  Contact regulation of cell division in an epithelial-like cell line.

Authors:  L N Castor
Journal:  J Cell Physiol       Date:  1968-12       Impact factor: 6.384

7.  Conditions determining initiation of DNA synthesis in 3T3 cells.

Authors:  R Dulbecco; M G Stoker
Journal:  Proc Natl Acad Sci U S A       Date:  1970-05       Impact factor: 11.205

8.  "Contact inhibition" of cell division in 3T3 cells.

Authors:  R W Holley; J A Kiernan
Journal:  Proc Natl Acad Sci U S A       Date:  1968-05       Impact factor: 11.205

9.  Stimulation of RNA synthesis and cell division in resting cells by a factor present in serum.

Authors:  G Todaro; Y Matsuya; S Bloom; A Robbins; H Green
Journal:  Wistar Inst Symp Monogr       Date:  1967

10.  The initiation of cell division in a contact-inhibited mammalian cell line.

Authors:  G J Todaro; G K Lazar; H Green
Journal:  J Cell Physiol       Date:  1965-12       Impact factor: 6.384

View more
  21 in total

1.  Culture conditions for arresting and stimulating the proliferation of a rainbow trout fibroblast cell line, RTG-2.

Authors:  L E Lee; A Martinez; N C Bols
Journal:  In Vitro Cell Dev Biol       Date:  1988-08

2.  Morphological and functional differentiation of cultured vascular smooth-muscle cells.

Authors:  M Tagami; Y Nara; A Kubota; T Sunaga; H Maezawa; H Fujino; Y Yamori
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

3.  Interactions of insulin, insulinlike growth factor II, and platelet-derived growth factor in erythropoietic culture.

Authors:  N Dainiak; S Kreczko
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

4.  Analysis of the reduced growth factor dependency of simian virus 40-transformed 3T3 cells.

Authors:  S Powers; P B Fisher; R Pollack
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

5.  Cytoplasmic transfer of the mitogenic response to platelet-derived growth factor.

Authors:  J C Smith; C D Stiles
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

Review 6.  Density-dependent regulation of cell growth: an example of a cell-cell recognition phenomenon.

Authors:  M A Lieberman; L Glaser
Journal:  J Membr Biol       Date:  1981       Impact factor: 1.843

7.  Regulation of human amnion cell growth and morphology by sera, plasma, and growth factors.

Authors:  E V Gaffney; M A Grimaldi
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

8.  Mitogenic factors present in serum but not in plasma.

Authors:  S D Balk; S P Levine; L L Young; M M LaFleur; N M Raymond
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

9.  Fine structure of arterial smooth muscle cells cultured in the presence of whole blood serum or plasma-derived serum.

Authors:  J Nilsson; J Thyberg
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

10.  Platelet-derived growth factor promotes proliferation of erythropoietic progenitor cells in vitro.

Authors:  N Dainiak; G Davies; M Kalmanti; J Lawler; V Kulkarni
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.